Tetra Bio-Pharma Inc.

TSX:TBP Stock Report

Market Cap: CA$12.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Tetra Bio-Pharma Management

Management criteria checks 3/4

Tetra Bio-Pharma's CEO is Guy Chamberland, appointed in Apr 2018, they has a tenure of 5.17 years. They directly owns 0.06% of the company’s shares, worth CA$7.77K. The average tenure of the management team and the board of directors is 2.8 years and 5.7 years respectively.`

Key information

Guy Chamberland

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.2yrs
CEO ownership0.06%
Management average tenure2.8yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

Does Tetra Bio-Pharma (TSE:TBP) Have A Healthy Balance Sheet?

Sep 14
Does Tetra Bio-Pharma (TSE:TBP) Have A Healthy Balance Sheet?

CEO Compensation Analysis

How has Guy Chamberland's remuneration changed compared to Tetra Bio-Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Aug 31 2022n/an/a

-CA$39m

May 31 2022n/an/a

-CA$41m

Feb 28 2022n/an/a

-CA$45m

Nov 30 2021CA$437kCA$325k

-CA$52m

Aug 31 2021n/an/a

-CA$29m

May 31 2021n/an/a

-CA$28m

Feb 28 2021n/an/a

-CA$25m

Nov 30 2020CA$472kCA$298k

-CA$21m

Aug 31 2020n/an/a

-CA$17m

May 31 2020n/an/a

-CA$15m

Feb 29 2020n/an/a

-CA$14m

Nov 30 2019CA$295kCA$214k

-CA$13m

Aug 31 2019n/an/a

-CA$14m

May 31 2019n/an/a

-CA$10m

Feb 28 2019n/an/a

-CA$10m

Nov 30 2018CA$263kCA$191k

-CA$8m

Aug 31 2018n/an/a

-CA$5m

May 31 2018n/an/a

-CA$8m

Feb 28 2018n/an/a

-CA$7m

Nov 30 2017CA$153kCA$153k

-CA$6m

Aug 31 2017n/an/a

-CA$5m

May 31 2017n/an/a

-CA$4m

Feb 28 2017n/an/a

-CA$2m

Nov 30 2016CA$131kCA$60k

-CA$944k

Compensation vs Market: Insufficient data to establish whether Guy's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Guy's compensation has been consistent with company performance over the past year.

CEO

Guy Chamberland (61 yo)

5.2yrs

Tenure

CA$436,642

Compensation

Dr. Guy Chamberland, M.Sc., Ph D., Master Herbalist, has been the Chief Executive Officer and Chief Regulatory Officer at Tetra Bio-Pharma Inc. since October 15, 2018 and serves as its Director since June...

Leadership Team

NamePositionTenureCompensationOwnership
Guy Chamberland
Co-Founder5.2yrsCA$436.64k0.060%
CA$ 7.8k
Steeve Néron
Chief Commercial Officer2.8yrsCA$313.61kno data
André Rancourt
Co-Founderno datano datano data
Leslie Auld
Chief Financial Officer1.1yrsno datano data
Jennifer McCaughey
Vice President of Investor Relationsno datano datano data
Dania Scott
Senior Vice President of Commercial Strategy2.8yrsno datano data
Aurelia Pauw
Senior VP of Clinical Programs & Medical Affairs2.4yrsno datano data
Richard Giguere
Chief Executive Officer of Tetra Natural Health Inc.4.7yrsno datano data
Randy Ringuette
Project Director & Member of Advisory Boardno datano datano data
Chris MacLean
Chief Operating Officer of Tetra Natural Health4.1yrsno datano data

2.8yrs

Average Tenure

Experienced Management: TBP's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Guy Chamberland
Co-Founder4yrsCA$436.64k0.060%
CA$ 7.8k
Randy Ringuette
Project Director & Member of Advisory Board7.6yrsno datano data
Catherine Auld
Independent Director2.1yrsCA$56.76kno data
Steven Edgett
Member of Strategic Advisor2.9yrsno datano data
Brent Norton
Independent Chairman2.8yrsCA$151.76kno data
Adam Greenblatt
Member of Advisory Board7.6yrsno datano data
Erin Prosk
Member of Advisory Board7.6yrsno datano data
Charles Campbell
Member of Advisory Board7.6yrsno datano data
Louis-Philippe de Lorimier
Member of Clinical Advisory Board5.8yrsno datano data
Cheryl Cullen
Member of Clinical Advisory Board5.7yrsno datano data
Aubrey Webb
Member of Clinical Advisory Board5.7yrsno datano data
John Kim
Independent Director2.1yrsCA$56.76k0.096%
CA$ 12.4k

5.7yrs

Average Tenure

61yo

Average Age

Experienced Board: TBP's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/03 08:47
End of Day Share Price 2023/03/06 00:00
Earnings2022/08/31
Annual Earnings2021/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tetra Bio-Pharma Inc. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rahul SarugaserParadigm Capital, Inc.